A detailed history of Alliance Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Alliance Wealth Advisors, LLC holds 5,100 shares of ABBV stock, worth $841,449. This represents 0.56% of its overall portfolio holdings.

Number of Shares
5,100
Previous 4,985 2.31%
Holding current value
$841,449
Previous $855,000 17.78%
% of portfolio
0.56%
Previous 0.53%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $18,841 - $22,922
115 Added 2.31%
5,100 $1.01 Million
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $10,835 - $12,653
-70 Reduced 1.38%
4,985 $855,000
Q1 2024

Apr 16, 2024

SELL
$159.82 - $182.1 $33,881 - $38,605
-212 Reduced 4.03%
5,055 $920,000
Q4 2023

Jan 10, 2024

BUY
$137.6 - $154.97 $137 - $154
1 Added 0.02%
5,267 $816,000
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $58,171 - $72,391
-439 Reduced 7.7%
5,266 $709,000
Q1 2023

Apr 06, 2023

SELL
$144.61 - $166.54 $5,205 - $5,995
-36 Reduced 0.63%
5,705 $909,000
Q4 2022

Jan 23, 2023

SELL
$138.31 - $165.87 $52,972 - $63,528
-383 Reduced 6.25%
5,741 $0
Q3 2022

Oct 11, 2022

SELL
$134.21 - $153.93 $19,057 - $21,858
-142 Reduced 2.27%
6,124 $822,000
Q2 2022

Jul 20, 2022

SELL
$137.62 - $174.96 $66,745 - $84,855
-485 Reduced 7.18%
6,266 $960,000
Q1 2022

Apr 12, 2022

SELL
$131.98 - $163.75 $51,208 - $63,535
-388 Reduced 5.43%
6,751 $1.09 Million
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $21,593 - $27,321
201 Added 2.9%
7,139 $967,000
Q3 2021

Oct 12, 2021

BUY
$106.4 - $120.78 $17,130 - $19,445
161 Added 2.38%
6,938 $748,000
Q2 2021

Jul 27, 2021

SELL
$105.21 - $117.21 $11,467 - $12,775
-109 Reduced 1.58%
6,777 $763,000
Q1 2021

Apr 14, 2021

SELL
$102.3 - $112.62 $1.43 Million - $1.57 Million
-13,972 Reduced 66.99%
6,886 $745,000
Q4 2020

Mar 09, 2021

BUY
$80.49 - $108.67 $1.68 Million - $2.27 Million
20,858 New
20,858 $2.24 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Alliance Wealth Advisors, LLC Portfolio

Follow Alliance Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliance Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alliance Wealth Advisors, LLC with notifications on news.